Seegene
Private Company
Funding information not available
Overview
Seegene is a leading molecular diagnostics company that has built a comprehensive ecosystem around PCR technology over its 25-year history. Its core offerings include the Allplex™ high-multiplex assay platform, the CURECA™ automated workflow system, and the STAgora™ cloud-based data intelligence platform. The company is pursuing a unique Technology-Sharing Initiative to expand global access to its proprietary technologies through strategic partnerships. With a presence in over 100 countries, Seegene aims to leverage automation and real-time data to transform global healthcare diagnostics.
Technology Platform
Integrated ecosystem comprising: 1) Allplex™ high-multiplex real-time PCR assay technology, 2) CURECA™ automated modular diagnostic system, and 3) STAgora™ cloud-based data intelligence and surveillance platform.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Seegene competes in the crowded molecular diagnostics market against large, diversified players like Roche, Abbott, and Thermo Fisher, as well as other MDx specialists. Its differentiation lies in its high-multiplex PCR assays, full-stack automation, and unique technology-sharing partnership model.